Mefenamic Acid and Warfarin Interaction

Drug interaction information between Mefenamic Acid and Warfarin.

Mefenamic Acid and Warfarin have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Mefenamic Acid and Warfarin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Mefenamic Acid

Nonsteroidal Anti-Inflammatory Drug (NSAID)

Drug B

Warfarin

Vitamin K Antagonist (Anticoagulant)

How They Interact

Mefenamic acid can increase the risk of bleeding when used with warfarin. These drugs work together to slow down blood clotting more than usual.

Warfarin Also Interacts With

View all Warfarin interactions →

Frequently Asked Questions

What SPL severity band is on file for Mefenamic Acid + Warfarin?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Warfarin has 163 labeled pairs on file vs Mefenamic Acid's 15. In the moderate band specifically: Mefenamic Acid has 3 (also Methotrexate, Diflunisal); Warfarin has 28 (also Ibuprofen, Aspirin, Diclofenac, Desvenlafaxine).

What mechanism field is on file for Mefenamic Acid and Warfarin?

Mefenamic acid can increase the risk of bleeding when used with warfarin. These drugs work together to slow down blood clotting more than usual.

Warfarin carries more major-labeled pairs than Mefenamic Acid

SPL source-record counts only. This page's band is moderate · classes on file: Mefenamic Acid (Nonsteroidal Anti-Inflammatory Drug (NSAID)); Warfarin (Vitamin K Antagonist (Anticoagulant)).

Warfarin has 2 major-labeled pairs vs Mefenamic Acid's 0. This page itself is in the moderate band, not the major band.

Mefenamic Acid

0 major · 3 moderate · 12 minor · 15 total

Warfarin

2 major · 28 moderate · 133 minor · 163 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.